ClinicalTrials.Veeva

Menu

Human Epidemiology of Newly Identified Arboviruses (ARBODOCC)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Enrolling

Conditions

SARS-CoV Infection
Arbovirus Infections

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT04954352
RECHMPL21_0297

Details and patient eligibility

About

A local network is being set up to study the impact of arboviruses in our region. It is committed to a one-health approach, in particular with research without a priori for new viruses hosted among vectors and wildlife. The candidates identified by high throughput sequencing approaches will serve as a basis for the development of serological and molecular tools for their detections. These tools will be used to assess the possible circulation of these new viruses in humans in biological collections created within the framework of this project Arbodocc

.

Enrollment

400 estimated patients

Sex

All

Ages

Under 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients admitted at the Monpellier University Hospital for any infectious syndrome compatible with an arboviral infection with samples available

Exclusion criteria

  • Informed consent non obtain for samples used

Trial contacts and locations

1

Loading...

Central trial contact

Yannick Simonin, PhD; Vincent Foulongne, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems